What is he best known for?
The fields of study he is best known for:
John D. Groopman spends much of his time researching Aflatoxin, Carcinogen, Hepatocellular carcinoma, Biochemistry and Pharmacology.
His Aflatoxin study integrates concerns from other disciplines, such as Urine, Toxicology, Mycotoxin and Public health.
His biological study spans a wide range of topics, including Virology, Carcinogenesis, Antigen, Molecular biology and Radioimmunoassay.
His biological study focuses on Liver cancer.
His work on Affinity chromatography, DNA damage, Transfection and DNA is typically connected to Debrisoquine as part of general Biochemistry study, connecting several disciplines of science.
John D. Groopman interconnects Erythromycin breath test, Oltipraz, In vivo and Sulforaphane in the investigation of issues within Pharmacology.
His most cited work include:
- SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. (594 citations)
- Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma (561 citations)
- A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. (558 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Aflatoxin, Carcinogen, Biochemistry, Hepatocellular carcinoma and Liver cancer.
His Aflatoxin study combines topics from a wide range of disciplines, such as Cancer, Toxicology, Mycotoxin, Urine and Chromatography.
In Carcinogen, John D. Groopman works on issues like Oltipraz, which are connected to Anticarcinogen.
His Biochemistry research focuses on subjects like Molecular biology, which are linked to In vivo and Mutation.
His studies deal with areas such as Hepatitis B, Immunology, Virology and Pathology as well as Hepatocellular carcinoma.
John D. Groopman has researched Liver cancer in several fields, including Epidemiology, Incidence, Environmental health, Vaccination and Cohort.
He most often published in these fields:
- Aflatoxin (40.92%)
- Carcinogen (23.63%)
- Biochemistry (20.75%)
What were the highlights of his more recent work (between 2016-2021)?
- Aflatoxin (40.92%)
- Internal medicine (15.85%)
- Hepatocellular carcinoma (19.02%)
In recent papers he was focusing on the following fields of study:
John D. Groopman mainly investigates Aflatoxin, Internal medicine, Hepatocellular carcinoma, Cohort and Liver cancer.
His Aflatoxin research is multidisciplinary, incorporating perspectives in Cancer research, Environmental health, Carcinogen, Plasma samples and Mycotoxin.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Cancer, microRNA, DNA and Medical physics.
Within one scientific family, John D. Groopman focuses on topics pertaining to Chromatography under DNA, and may sometimes address concerns connected to DNA damage.
His research integrates issues of Mortality rate, Demography, Sex ratio, Etiology and Physiology in his study of Liver cancer.
Between 2016 and 2021, his most popular works were:
- Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances (56 citations)
- Exposure to aflatoxin and fumonisin in children at risk for growth impairment in rural Tanzania (56 citations)
- Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. (32 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Hepatocellular carcinoma, Aflatoxin, Cancer, Physiology and Cohort.
In his study, which falls under the umbrella issue of Hepatocellular carcinoma, Chromatography, Adduct, Liquid chromatography–mass spectrometry, Guanine and Isotope dilution is strongly linked to DNA.
His Aflatoxin study frequently links to related topics such as microRNA.
His work on Carcinogenesis as part of general Cancer research is frequently linked to Systemic therapy, bridging the gap between disciplines.
As a member of one scientific family, John D. Groopman mostly works in the field of Environmental exposure, focusing on Hepatitis B and, on occasion, Liver cancer.
His work focuses on many connections between Incidence and other disciplines, such as Gallstones, that overlap with his field of interest in Carcinogen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
